Søgning på udtrykket 'vaccination' giver 66 resultater


Dokumenter [6] Sider [1] Kalender [18] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [6]

Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab

Væsentlige ændringer siden sidste version (fra 2013): 1) Anbefaling af at alle patienter, der tilhører de af SST definerede risikogrupper, med nyopstået influenza (indenfor de to første døgn) under et udbrud behandles med oseltamivir for at reducere risiko for efterfølgende kompliceret influenza. En opgave som især primær praksis og ambulatorier med sådanne patienter i langvarige forløb skal være opmærksom på. 2) Revision af håndtering af influenza sygdom på lokalisationer med adgang til…

Anbefaling for profylakse og opfølgning af stikuheld og anden blodeksposition. Arbejdsgruppe: Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis

Denne vejledning er tiltænkt behandling af CVID hos voksne patienter. Der er ikke foretaget en gradering af evidensniveau, da der ikke foreligger solid evidens for flere dele af feltet.

Denne vejledning er tiltænkt diagnostik og kontrol af CVID hos voksne patienter. Der er ikke foretaget en gradering af evidensniveau, da der ikke foreligger solid evidens for flere dele af feltet.

Ved Hanna M. Nohynek, MD PhD, Head of Unit, National Institute for Health and Welfare, THL, Dept Vaccines and Immune Protection, Vaccine Programme Unit, Helsinki, Finland

Sider [1]

…nationalt automatisk overvågningssystem til overvågning af infektioner erhvervet i sundhedssektoren. www.esundhed.dk/Emner/Patienter-og-sygehuse/HAIBA. MicrobeTV. Podcasts om bl.a. virus, parasitter og andre mikroorganismer. www.microbe.tv. SSI. Statens Serums Institut's overvågningsdata vedrørende vaccinationsdækning og sygdomsforekomst.. statistik.ssi.dk.                      .  .  .


Kalender [18]

2. juni, Auditorium 93, Rigshospitalet
19. maj, Online og Aarhus Universitetshospital
21. september 2021, Online
27. maj 2021, Online
22. marts 2021, Online
4. maj 2020, Statens Serum Institut
25. november 2019, Auditorium 3 og 4, Hvidovre Hospital
1. april 2019, København
24. januar 2019, Aarhus Universitetshospital
27. september 2017, Syddansk Universitet
8. maj 2017, København
29. april 2016, Hindsgavl, Middelfart
8. marts 2016, Kommunehospitalet, København
13. april 2015, Statens Serum Institut
7. april 2014, Statens Serum Institut, København
8. april 2013, Statens Serum Institut
14. januar 2013, Auditorium 2, Rigshospitalet

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
1.07.2022
…for VAERS population). . Conclusions. Myocarditis and pericarditis following COVID-19 vaccination are very rare, and benefits of COVID-19 vaccination continue to outweigh any perceived risks. Reporting rates of myocarditis and pericarditis were similar in immunocompromised individuals, however defining characteristics differed compared with the whole population; therefore, continued monitoring of adverse events following vaccination remains vital to understand differences between population subgroups. .
Journal of Infectious Diseases
1.07.2022
…of 216,113 vaccinees and were more common in younger children (age 2-8, 1.2%) compared with older children (age 9-17, 0.4%) and adults (0.7%). Fever and headache were the most reported symptoms. All 17 SAE related to vaccine were in 2-8 year-olds (10 post-vaccination febrile convulsions +/- gastroenteritis and 7 fever and/or gastroenteritis) The incidence of febrile seizures was 8/26,062 (0.031%) prior to initiation of routine acetaminophen in December 2020 and 2/15,897 (0.013%) thereafter. Non-obstetric SA…
International Journal of Infectious Diseases
1.07.2022
Since January 2022, and as of 15th June 2022, a total of 2103 laboratory-confirmed cases of monkeypox, including one death, have been reported to the WHO from 42 countries in five of six WHO regions (WHO 2022a; ECDC 2022). The majority (84%) of confirmed cases (n=1773) are in the WHO European Region, and only a few have a travel history to endemic countries in Africa.
International Journal of Infectious Diseases
30.06.2022
Introduction
PLoS One Infectious Diseases
29.06.2022
by Joseph Agebase Awuni, Michael Ayamga, Gilbert Dagunga. Purpose The study examined Covid-19 vaccinations intentions among literate Ghanaians and how it is been influenced by vaccine mistrust and the fear of the unforeseen side effects. Design/Methodology/Approach We used cross sectional data collected from 223 respondents by means of questionnaire disseminated through social media from 16th to 20th April, 2021. Likert-scale questions were asked regarding the knowledge, attitudes and perceptions of liter…
New England Journal of Medicine
29.06.2022
New England Journal of Medicine, Volume 386, Issue 26, June 2022.
BMJ Open
29.06.2022
…the effectiveness and durability of protection against SARS-CoV-2 infection conferred by previous infection and COVID-19 is essential to inform ongoing management of the pandemic. This study aims to determine whether prior SARS-CoV-2 infection or COVID-19 vaccination in healthcare workers protects against future infection. . Methods and analysis. This is a prospective cohort study design in staff members working in hospitals in the UK. At enrolment, participants are allocated into cohorts, positive or na…
Lancet Infectious Diseases
29.06.2022
Whole-virion inactivated SARS-CoV-2 vaccines are one of the most widely used vaccines worldwide. However, compared with the mRNA-based and adenovirus-based platforms,1 little information is available about the immune response that is induced by inactivated virus vaccines2 and the convenience of applying heterologous boosters to reach an improved response against variants of concern, including omicron (B.1.1.529). Particularly scarce are data for older people (ie, age >60 years).
Clinical Microbiology and Infection
29.06.2022
The diffusion of the SARS-CoV-2 delta (B.1.617.2) variant and the waning of immune response after primary Covid-19 vaccination favoured the breakthrough SARS-CoV-2 infections in vaccinated subjects. To assess the impact of vaccination, we determined the severity of infection in hospitalised patients according to vaccine status.
PLoS One Infectious Diseases
28.06.2022
… Nicolaus Burger, Matthias Mayer, Ivo Steimanis. Background Many countries, such as Germany, struggle to vaccinate enough people against COVID-19 despite the availability of safe and efficient vaccines. With new variants emerging and the need for booster vaccinations, overcoming vaccination hesitancy gains importance. The research to date has revealed some promising, albeit contentious, interventions to increase vaccination intention. However, these have yet to be tested for their effectiveness in increasi…
Journal of Medical Virology
27.06.2022
Journal of Medical Virology, Accepted Article.
Journal of Medical Virology
25.06.2022
Journal of Medical Virology, Accepted Article.
Lancet Infectious Diseases
25.06.2022
It is widely accepted that vaccination is key to bringing the COVID-19 pandemic under control by preventing severe disease. Due to the global disease distribution and diverse populations affected, multiple vaccine platforms are needed to overcome limitations in manufacture, logistics, and efficacy. Despite the global administration of up to 11·84 billion doses1 of COVID-19 vaccine to healthy adults and people at increased risk of disease, vaccinations for children are an emerging consideration.
Lancet Infectious Diseases
24.06.2022
In The Lancet Infectious Diseases, Aaron M Samuels and colleagues1 assessed the efficacy of fractional RTS,S/AS01E (hereafter referred to as RTS,S) vaccines doses against malaria. The study design of this clinical trial was based on findings from a phase 2a controlled human malaria infection (CHMI) study assessing vaccine efficacy in adults,2 and from a study evaluating the effect of a change in the vaccine regimen on the quality of antibody responses.3
Lancet Infectious Diseases
24.06.2022
Over the course of the first year of COVID-19 vaccination, between Dec 8, 2020, and Dec 8, 2021, 8·33 billion doses were administered among 4·36 billion people globally.1 In their study in The Lancet Infectious Diseases, by fitting a mathematical model to excess mortality, Oliver J Watson and colleagues2 estimated that in 185 countries and territories 31·4 million COVID-19-related deaths would have occurred during this timeframe in the absence of COVID-19 vaccination. They estimated that 19·8 million de…
Lancet Infectious Diseases
24.06.2022
COVID-19 vaccination has substantially altered the course of the pandemic, saving tens of millions of lives globally. However, inadequate access to vaccines in low-income countries has limited the impact in these settings, reinforcing the need for global vaccine equity and coverage.
International Journal of Infectious Diseases
24.06.2022
Letter to the Editor
International Journal of Infectious Diseases
24.06.2022
Dear Dr. Petersen
Clinical Infectious Diseases
23.06.2022
AbstractThe National Immunization Survey Adult COVID Module used a random-digit-dialed phone survey during April 22, 2021–January 29, 2022 to quantify COVID-19 vaccination, intent, attitudes, and barriers by detailed race/ethnicity, interview language, and nativity. Foreign-born respondents overall and within racial/ethnic categories had higher vaccination coverage (80.9%), higher intent to be vaccinated (4.2%), and lower hesitancy towards COVID-19 vaccination (6.0%) than US-born respondents (72.6%, 2.9%,…
Lancet Infectious Diseases
23.06.2022
We recently conducted a systematic review and meta-regression of the duration of effectiveness of primary series COVID-19 vaccination against clinical outcomes before the predominance of the omicron (B.1.1.529) SARS-CoV-2 variant.1 Here we assess the duration of vaccine protection, after a primary vaccine series and after the first booster dose, against omicron, the current predominant variant, using the same methods.1

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Morbidity and Mortality Weekly Report (MMWR)
30.06.2022
This report describes COVID-19 vaccine provider availability and vaccination coverage among children aged 5-11.
Medscape Infectious Diseases
30.06.2022
Immunity against new Omicron variants is getting weaker and weaker. Is another vaccination with the available vaccines worth it? .
Eurosurveillance latest updates
30.06.2022
Compared with individuals unvaccinated in the current and three previous influenza seasons, in 2021/22, influenza vaccine effectiveness at primary care level was 37% (95% CI: 16 to 52) for current season vaccination, regardless of previous doses, and 35% (95% CI: −3 to 45) for only previous seasons vaccination. Against influenza A(H3N2), estimates were 39% (95% CI: 16 to 55) and 24% (95% CI: −8 to 47) suggesting moderate effectiveness of current season vaccination and possible remaining effect o…
Medscape Infectious Diseases
28.06.2022
New cases of COVID-19 continue to drop among children, but the vaccination effort in those under age 5 years began with something less than a bang. .
ProMED
24.06.2022
Anthrax -- United States
Medscape Infectious Diseases
21.06.2022
COVID rates after vaccination are relatively low and cases mild in patients with multiple sclerosis treated with disease-modifying therapies – but vaccine antibody response is lower with anti-CD20 therapies. .
Medscape Infectious Diseases
20.06.2022
The nation's infants, toddlers, and preschoolers are finally getting their chance at COVID-19 vaccination as the US rolls out shots for tots this week. .
Eurosurveillance latest updates
16.06.2022
…f transmission. It further presents the vaccination strategy adopted to control the outbreak. The phylogenetic evaluation demonstrated the close genetic proximity between the strain involved in this outbreak and a strain responsible for a larger epidemic that had occurred in 2015 and 2016 in the Tuscany Region. The rapid identification and characterisation of IMD cases and an extensive vaccination campaign contributed to the successful control of this outbreak caused by a hyperinvasive meningococcal strain.
Statens Serum Institut
15.06.2022
Risikoen for at få en lang række forskellige blodsygdomme efter covid-19-vaccinationer var lav. Det viser et nyt fælles studie med forskere fra Statens Serum Institut samt Norge og Finland.
Morbidity and Mortality Weekly Report (MMWR)
9.06.2022
This report describes COVID-19 vaccination coverage by race and ethnicity.
Morbidity and Mortality Weekly Report (MMWR)
27.05.2022
This report describes ACIP's 2021 vaccine recommendation, JYNNEOS, against orthopoxviruses such as smallpox, monkeypox, and cowpox.
Eurosurveillance latest updates
26.05.2022
…atic infection. . . Methods. Individuals with COVID-19 or acute respiratory symptoms at primary care/community level in 10 European countries were tested for SARS-CoV-2. We measured complete primary course overall VE by vaccine brand and by time since vaccination. . . Results. Overall VE was 74% (95% CI: 69–79), 76% (95% CI: 71–80), 63% (95% CI: 48–75) and 63% (95% CI: 16–83) among those aged 30–44, 45–59, 60–74 and ≥ 75 years, respectively…
Medscape Infectious Diseases
19.05.2022
In trying to simplify recommendations and make rabies immunization less expensive, the CDC designated five risk levels with different advice based on the level of risk. .
Eurosurveillance latest updates
19.05.2022
…sion and not by vaccination, variant or time from vaccination. . . Conclusions. Vaccination was protective during the Delta variant wave, as suggested by older age and greater immunosuppression in vaccinated breakthrough vs unvaccinated inpatients. Nevertheless, compared with an earlier post-vaccination period, breakthrough infections 6 months post-vaccination occurred in healthier patients. Thus, waning immunity increased vulnerability during the Delta wave, which suggests boosters as a countermeasure.
Morbidity and Mortality Weekly Report (MMWR)
5.05.2022
This report describes updates from Advisory Committee On Immunization Practices on rabies PrEp recommendations.
Eurosurveillance latest updates
5.05.2022
. Background. Omicron subvariant BA.2 circulation is rapidly increasing globally. . . Aim. We evaluated the neutralising antibody response from vaccination or prior SARS-CoV-2 infection against symptomatic infection by BA.2 or other variants. . . Methods. Using 50% plaque reduction neutralisation tests (PRNT50), we assessed neutralising antibody titres to BA.2, wild type (WT) SARS-CoV-2 and other variants in Comirnaty or CoronaVac vaccinees, with or without prior WT-SARS-CoV-2 infection. Titres we…
WHO disease outbreak news
29.04.2022
Vaccines against human papillomavirus (HPV) have been in use for 15 years. Clinical trials demonstrated early on that these vaccines are safe and effective. Those countries that have achieved high rates of HPV vaccination coverage have already demonstrated the real-world impact of vaccination: significant reductions in HPV infections, precancerous cervical lesions (CIN) and genital warts, the latter in both females and males. .
WHO disease outbreak news
28.04.2022
According to the latest data available, 85% of eligible children in Ukraine received their first dose of measles vaccine in 2020. While this was a significant improvement compared to the low of 42% in 2016 and a major achievement for the country, WHO recommends vaccine coverage of 95% or higher each year to achieve and maintain herd immunity and protect the population. With the ongoing war leading to severe disruptions to the Ukrainian health system including routine immunizations, WHO is seriously concerne…

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,47 s

Cookies og privatliv